Humira 40mg/0.4ml (2 pin)

Product Description:
Humira is a prescription medication that contains adalimumab, a recombinant human monoclonal antibody that effectively inhibits tumor necrosis factor-alpha (TNF-alpha), a key cytokine involved in inflammatory processes. By blocking TNF-alpha, Humira significantly reduces inflammation and slows disease progression in various autoimmune conditions.

Formulation: Solution for injection
Strength: 40 mg of adalimumab per 0.4 mL
Presentation: Prefilled syringe or pen
Pack Size: Available in packs of 1, 2, or 6 single-dose prefilled syringes or pens.

Indications:
Humira is indicated for the treatment of several autoimmune conditions, including:
- Rheumatoid arthritis
- Ankylosing spondylitis
- Psoriatic arthritis
- Crohn's disease
- Ulcerative colitis
- Hidradenitis suppurativa
- Plaque psoriasis
- Non-infectious uveitis

Dosage & Administration:
- Rheumatoid Arthritis: Initially, 40 mg every other week.
- Ankylosing Spondylitis: Initially, 40 mg every other week.
- Psoriatic Arthritis: Initially, 40 mg every other week.
- Crohn's Disease: Initially, 160 mg (4 injections of 40 mg each) at week 0, followed by 80 mg at week 2, then 40 mg every other week starting at week 4.
- Ulcerative Colitis: Initially, 160 mg (4 injections of 40 mg each) at week 0, followed by 80 mg at week 2, then 40 mg every other week starting at week 4.
- Hidradenitis Suppurativa: Initially, 160 mg (4 injections of 40 mg each) at week 0, followed by 80 mg at week 2, then 40 mg every other week starting at week 4.
- Plaque Psoriasis: Initially, 80 mg at week 0, followed by 40 mg every other week starting at week 1.
- Non-infectious Uveitis: Initially, 80 mg at week 0, followed by 40 mg every other week starting at week 1.

The exact dosing schedule may vary based on the specific condition and patient response. It is essential to follow the prescribing healthcare provider's instructions.

Clinical Benefits:
- Reduces signs and symptoms of the disease
- Improves physical function
- Slows the progression of structural damage
- Enhances quality of life

Key Specifications:
- Active Ingredient: Adalimumab
- Excipients: Mannitol, polysorbate 80, water for injections

Warnings & Contraindications:
- Contraindications:
- Hypersensitivity to adalimumab or any component of the formulation
- Active infections, including tuberculosis
- Moderate to severe heart failure
- Warnings:
- Risk of serious infections
- Potential for malignancies
- Risk of demyelinating diseases
- Potential for reactivation of latent tuberculosis

Side Effects:
- Injection site reactions (e.g., redness, swelling, pain)
- Headache
- Upper respiratory infections
- Nausea
- Rash
- Increased risk of serious infections
- Potential for malignancies

For comprehensive information, including detailed dosing schedules and potential side effects, refer to the official prescribing information or consult a healthcare professional.

---

All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.